inhibitor

Phase 2 Spring Trial of LHP588, a Treatment for P. Gingivalis-positive Alzheimer’s Disease, Continues as Planned Alzheimer’s disease is a...

CIMZIA, a medication used to treat rheumatoid arthritis (RA), has shown significant efficacy in patients with elevated levels of rheumatoid...

Discovering Key Clues to DNA Repair Mechanism: A Potential Pathway for Advancing Cancer Treatments Cancer continues to be one of...

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recently recommended the approval of Mirati...

Using the Probability of Being in Response (PBR) in the REACH3 Study: A Novel Method to Visualize Clinical Benefit of...

The Potential of Blocking Proteins to Disrupt Energy Supply in Colon Tumors Colon cancer, also known as colorectal cancer, is...

Newly Published Guidance Recommends BMS Cardiac Myosin Inhibitor for Treatment In recent years, there have been significant advancements in the...

Title: Enhancing Cancer Immunotherapy in Mice: Unveiling the Potential of Rescuing Dendritic Cells from Glycolysis Inhibition Introduction: Cancer immunotherapy has...

Introduction of Trial-first Approach for Roche’s ALK Inhibitor in Lung Cancer Treatment Lung cancer is one of the most prevalent...

Bristol Myers Receives Crucial FDA Approval for Drug Targeting Bone Marrow Disease Bristol Myers Squibb, a leading global biopharmaceutical company,...

Title: Targeting LGSN Induces Pyroptosis to Restore Chemotherapy Sensitivity in Gastric Cancer Stem Cells – Insights from Cell Death &...

The Role of Methionine in the Metabolism Vulnerability of Cisplatin Resistant Bladder Cancer Microenvironment – A Study in Cell Death...

The Environmental Protection Agency (EPA) in New Zealand has recently approved the use of the country’s first methane inhibitor, which...

Understanding How Recludix Utilizes SH2 Domains to Target STATs The field of molecular biology has made significant strides in recent...